BioMark is the Chairman of Stonehage Fleming (UK) Limited, he joined FF&P as a Board Director and Chairman of FF&P Asset Management in 2003 and was appointed Group CEO in 2008.
Prior to that he spent 25 years building GNI which became one of the largest derivative broking businesses in London before it was acquired by the Gerrard Group in 1994. In 1996 he became Chief Executive of Gerrard Group which was acquired by ....
Education